• Titilope Oduyebo, Emily E Petersen, Sonja A Rasmussen, Paul S Mead, Dana Meaney-Delman, Christina M Renquist, Sascha R Ellington, Marc Fischer, J Erin Staples, Ann M Powers, Julie Villanueva, Romeo R Galang, Ada Dieke, Jorge L Muñoz, Margaret A Honein, and Denise J Jamieson.
• MMWR Morb. Mortal. Wkly. Rep. 2016 Feb 12; 65 (5): 122-7.

AbstractCDC has updated its interim guidelines for U.S. health care providers caring for pregnant women during a Zika virus outbreak (1). Updated guidelines include a new recommendation to offer serologic testing to asymptomatic pregnant women (women who do not report clinical illness consistent with Zika virus disease) who have traveled to areas with ongoing Zika virus transmission. Testing can be offered 2-12 weeks after pregnant women return from travel. This update also expands guidance to women who reside in areas with ongoing Zika virus transmission, and includes recommendations for screening, testing, and management of pregnant women and recommendations for counseling women of reproductive age (15-44 years). Pregnant women who reside in areas with ongoing Zika virus transmission have an ongoing risk for infection throughout their pregnancy. For pregnant women with clinical illness consistent with Zika virus disease,* testing is recommended during the first week of illness. For asymptomatic pregnant women residing in areas with ongoing Zika virus transmission, testing is recommended at the initiation of prenatal care with follow-up testing mid-second trimester. Local health officials should determine when to implement testing of asymptomatic pregnant women based on information about levels of Zika virus transmission and laboratory capacity. Health care providers should discuss reproductive life plans, including pregnancy intention and timing, with women of reproductive age in the context of the potential risks associated with Zika virus infection.

32 keywords...

hide…